CIK 0001799788
- Non-accelerated filer
- Smaller reporting company
Greenwich LifeSciences, Inc.
Sign in to watch- Ticker
- GLSI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205473709
- Phone
- +1 203-434-3290
- Business address
- 3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Patel Snehal CEO and CFO | Purchase | +3,400 | $12.95 | $44K | 5,547,102 |
| 2025-01-02 | Patel Snehal CEO and CFO | Purchase | +2,000 | $11.97 | $24K | 5,543,702 |
| 2024-12-31 | Patel Snehal CEO and CFO | Purchase | +2,400 | $11.36 | $27K | 5,541,702 |
| 2024-12-30 | Patel Snehal CEO and CFO | Purchase | +3,200 | $11.12 | $36K | 5,539,302 |
| 2024-11-21 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +1,000 | $12.91 | $13K | 264,148 |
| 2024-09-26 | Patel Snehal CEO and CFO | Purchase | +1,500 | $14.63 | $22K | 5,536,102 |
| 2024-08-12 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +800 | $13.85 | $11K | 263,148 |
| 2024-08-06 | Patel Snehal CEO and CFO | Purchase | +2,000 | $13.81 | $28K | 5,534,602 |
| 2024-08-05 | Patel Snehal CEO and CFO | Purchase | +5,500 | $13.18 | $72K | 5,532,602 |
| 2024-08-02 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +1,000 | $15.15 | $15K | 262,348 |
| 2024-07-23 | Patel Snehal CEO and CFO | Purchase | +1,500 | $15.89 | $24K | 5,527,102 |
| 2024-07-18 | Thompson Jaye VP Clinical Reg Affairs | Purchase | +1,000 | $16.00 | $16K | 261,348 |
| 2024-06-13 | Patel Snehal CEO and CFO | Purchase | +174,825 | $14.30 | $2.5M | 5,525,602 |
| 2024-04-01 | Patel Snehal CEO and CFO | Purchase | +3,000 | $19.08 | $57K | 5,350,777 |
| 2024-03-22 | Patel Snehal CEO and CFO | Purchase | +2,500 | $19.98 | $50K | 5,347,777 |
| 2024-03-20 | Patel Snehal CEO and CFO | Purchase | +1,500 | $17.68 | $27K | 5,345,277 |
| 2024-03-05 | Patel Snehal CEO and CFO | Purchase | +3,500 | $12.49 | $44K | 5,343,777 |
| 2024-03-05 | Patel Snehal CEO and CFO | Purchase | +30,500 | $12.49 | $381K | 5,343,777 |
| 2024-03-04 | Patel Snehal CEO and CFO | Purchase | +4,100 | $13.03 | $53K | 5,340,277 |
| 2024-02-16 | Patel Snehal CEO and CFO | Purchase | +10,800 | $11.16 | $121K | 5,336,177 |
Page 2 of 7 · 122 trades